appears in the following:

Federal Deal To Increase Vaccine Production Could Give Some Employees Early Access

Sunday, January 17, 2021

A federal manufacturing contract to increase COVID-19 vaccine production has an unusual clause that could move a company's employees and their families to the front of the vaccination line.

Comment

COVID-19 Supply Deal Lets Vaccine Maker Earmark Doses For Employees And Their Families

Friday, January 15, 2021

Emergent BioSolutions is under contract with Operation Warp Speed to make COVID-19 vaccines, but the terms could allow employees and their families to get vaccinated ahead of schedule.

Comment

U.S. Government To Buy Additional 100 Million Doses Of Pfizer COVID-19 Vaccine

Wednesday, December 23, 2020

The federal government reaches an agreement with Pfizer to buy an additional 100 million doses of the COVID-19 vaccine. NPR explores what that means for the country's supply in the coming months.

Comment

Pfizer, BioNTech Reach Deal To Supply U.S. With More Vaccine Doses

Wednesday, December 23, 2020

The drugmakers will add an additional 100 million COVID-19 vaccine doses to the number that they are already supplying the government. They expect to deliver all the doses by July 31.

Comment

How Will Moderna Meet The Demand For Its COVID-19 Vaccine?

Thursday, December 17, 2020

Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.

Comment

If Pfizer Vaccine Is FDA Approved, What's Trump Administration's Plan For Buying It?

Thursday, December 10, 2020

With Pfizer's COVID-19 vaccine awaiting Food and Drug Administration authorization, there's speculation about when the U.S. will buy another batch of doses and whether it already missed its chance.

Comment

U.S. Government May Find It Hard To Get More Doses Of Pfizer's COVID-19 Vaccine

Thursday, December 10, 2020

A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.

Comment

Pfizer's Coronavirus Vaccine Supply Contract Excludes Many Taxpayer Protections

Tuesday, November 24, 2020

The $1.95 billion Operation Warp Speed contract excludes government rights to inventions or production know-how developed in the manufacture of the COVID-19 vaccine.

Comment

Novavax Posts Coronavirus Vaccine Contract That Government Didn't Disclose

Wednesday, November 11, 2020

The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.

Comment

HHS Released More Coronavirus Vaccine Contracts As Election Results Unfolded

Sunday, November 08, 2020

Newly released COVID-19 vaccine contracts include weakened protections against potential price gouging. Several key federal contracts still haven't been disclosed by the government.

Comment

Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections

Friday, November 06, 2020

To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.

Comment

After Months Of Questions, A Key Operation Warp Speed Adviser's Contract Emerges

Friday, October 30, 2020

Drug industry veteran Moncef Slaoui is a key figure in Operation Warp Speed's push to develop COVID-19 coronavirus vaccines. His employment terms raised concerns about potential conflicts of interest.

Comment

A Federal Coronavirus Vaccine Contract Released At Last, But Redactions Obscure Terms

Saturday, October 24, 2020

Most of the federal contracts with companies involved in the crash program to make COVID-19 vaccines haven't been made public. The lack of disclosure raises questions about accountability.

Comment

Will FDA Heed Its Outside Experts' Advice On COVID-19 Vaccines?

Friday, October 23, 2020

A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.

Comment

FDA Panel To Lay Regulatory Groundwork For COVID-19 Vaccine

Thursday, October 22, 2020

A milestone in the development of COVID-19 vaccines will take place Thursday when the Food and Drug Administration will ask a panel of experts for advice on how to evaluate the vaccines.

Comment

A Look At Why Johnson & Johnson Paused Coronavirus Vaccine Trial

Tuesday, October 13, 2020

The development of a coronavirus vaccine is nearing the finish, but there have been stumbles. NPR discusses the pause in Johnson & Johnson's trial and the testing stages of other vaccines.

Comment

Call For Administration's COVID-19 Vaccine Contracts To Be Disclosed

Saturday, October 10, 2020

Members of Congress and advocacy groups say Operation Warp Speed should release its contracts with vaccine makers after NPR reporting found the terms of many aren't public.

Comment

FDA Releases Long-Awaited COVID-19 Vaccine Guidance

Tuesday, October 06, 2020

The requirements laid out by the Food and Drug Administration in advice for drugmakers underscore why it's unlikely a vaccine could clear the agency before Election Day.

Comment

How Operation Warp Speed's Big Vaccine Contracts Could Stay Secret

Tuesday, September 29, 2020

More than $6 billion in federal funding has been routed through a firm that manages defense contracts, making the agreements subject to less federal scrutiny and transparency.

Comment

What To Know About Those $200 Drug Cards President Trump Promised

Friday, September 25, 2020

Health policy researchers say Trump may not be able to pay for the cards, which fall short of lasting policy changes to curb high drug prices.

Comment